The prevalence and prognosis of resistant hypertension in patients with heart failure

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Jin, Chun Na ^a   Liu, Ming ^a   Sun, Jing Ping ^a   Fang, Fang ^a   Wen, Yong Na ^a   Yu, Cheuk Man ^a   Lee, Alex Pui Wai ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALBUMIN; ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRIC ACID DERIVATIVE; SODIUM; WARFARIN; ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART FAILURE; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PREDICTIVE VALUE; PREVALENCE; PROGNOSIS; RESISTANT HYPERTENSION; SODIUM BLOOD LEVEL; SURVIVAL RATE; SURVIVAL TIME; UNIVERSITY HOSPITAL; BLOOD PRESSURE; CHINA; DRUG EFFECTS; HEART RATE; HEART STROKE VOLUME; HOSPITALIZATION; HYPERTENSION; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CHINA; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART RATE; HOSPITALIZATION; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; STROKE VOLUME; SURVIVAL RATE;

EID: 84918501403     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0114958     Document Type: Article

References (44)

1. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, et al. (2003) Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 289: 2363-2369.
2. Writing Group M, Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, et al. (2012) Heart Disease and Stroke Statistics-2012 Update: A Report From the American Heart Association. Circulation 125: E2-e220.
3. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, et al. (2003) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 289: 2560-2572.
4. De La Sierra A, Segura J, Banegas JR, Gorostidi M, De La Cruz JJ, et al. (2011) Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension 57: 898-902.
5. Egan BM, Zhao Y, Axon RN, Brzezinski WA, Ferdinand KC (2011) Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008. Circulation 124: 1046-1058.
6. Daugherty SL, Powers JD, Magid DJ, Tavel HM, Masoudi FA, et al. (2012) Incidence and prognosis of resistant hypertension in hypertensive patients. Circulation 125: 1635-1642.
7. McAdam-Marx C, Ye X, Sung JC, Brixner DI, Kahler KH (2009) Results of a retrospective, observational pilot study using electronic medical records to assess the prevalence and characteristics of patients with resistant hypertension in an ambulatory care setting. Clin Ther 31: 1116-1123.
8. Gupta AK, Nasothimiou EG, Chang CL, Sever PS, Dahlof B, et al. (2011) Baseline predictors of resistant hypertension in the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT): A risk score to identify those at high-risk. J Hypertens 29: 2004-2013.
9. Group AOaCftACR (2002) Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (allhat). JAMA 288: 2981-2997.
10. Bhatia RS, Tu JV, Lee DS, Austin PC, Fang J, et al. (2006) Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 355: 260-269.
11. Kostis JB, Davis BR, Cutler J, Grimm RH Jr, Berge KG, et al. (1997) Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group. JAMA 278: 212-216.
12. McKee PA, Castelli WP, McNamara PM, Kannel WB (1971) The natural history of congestive heart failure: The Framingham study. N Engl J Med 285: 1441-1446.
13. Sarafidis PA, Georgianos P, Bakris GL (2013) Resistant hypertension-Its identification and epidemiology. Nat Rev Nephrol 9: 51-58.
14. Persell S (2011) Prevalence of resistant hypertension in the United States 2003-2008. Hypertension 57: 1076-1080.
15. Jonsson A, Edner M, Alehagen U, Dahlstrom U (2010) Heart failure registry: A valuable tool for improving the management of patients with heart failure. Eur J Heart Fail 12: 25-31.
16. Raphael CE, Whinnett ZI, Davies JE, Fontana M, Ferenczi EA, et al. (2009) Quantifying the paradoxical effect of higher systolic blood pressure on mortality in chronic heart failure. Heart 95: 56-62.
17. Grigorian-Shamagian L, Gonzalez-JuAnatey JR, Vazquez R, Cinca J, Bayes-Genis A, et al. (2008) Association of blood pressure and its evolving changes with the survival of patients with heart failure. J Card Fail 14: 561-568.
18. Abraham WT, Fonarow GC, Albert NM, Stough WG, Gheorghiade M, et al. (2008) Predictors of inhospital mortality in patients hospitalized for heart failure: Insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). J Am Coll Cardiol 52: 347-356.
19. Nunez J, Nunez E, Fonarow GC, Sanchis J, Bodi V, et al. (2010) Differential prognostic effect of systolic blood pressure on mortality according to left-ventricular function in patients with acute heart failure. Eur J Heart Fail 12: 38-44.
20. Lee TT, Chen J, Cohen DJ, Tsao L (2006) The association between blood pressure and mortality in patients with heart failure. Am Heart J 151: 76-83.
21. Buiciuc O, Rusinaru D, Levy F, Peltier M, Slama M, et al. (2011) Low systolic blood pressure at admission predicts long-term mortality in heart failure with preserved ejection fraction. J Card Fail 17: 907-915.
22. Anand IS, Tam SW, Rector TS, Taylor AL, Sabolinski ML, et al. (2007) Influence of blood pressure on the effectiveness of a fixed-dose combination of isosorbide dinitrate and hydralazine in the African-American Heart Failure Trial. J Am Coll Cardiol 49: 32-39.
23. Moser M, Hebert PR (1996) Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials. J Am Coll Cardiol 27: 1214-1218.
24. Davies JE, Manisty CH, Petraco R, Barron AJ, Unsworth B, et al. (2013) First-in-man safety evaluation of renal denervation for chronic systolic heart failure: Primary outcome from REACH-Pilot study. Int J Cardiol 162: 189-192.
25. Bisognano JD, De Leeuw P, Bach DS, Lovett EG, Kaufman CL (2009) Improved functional capacity and cardiovascular structure after baroreflex activation therapy(trademark) in resistant hypertension patients with symptomatic heart failure: Results from european and united states trials of the Rheos(registered trademark) system. J Card Fail 15: S63.
26. Fagard RH, Celis H, Thijs L, Wouters S (2009) Regression of left ventricular mass by antihypertensive treatment: A meta-analysis of randomized comparative studies. Hypertension 54: 1084-1091.
27. Sarafidis PA, Bakris GL (2008) Resistant Hypertension. An Overview of Evaluation and Treatment. J Am Coll Cardiol 52: 1749-1757.
28. Persson H, Lonn E, Edner M, Baruch L, Lang CC, et al. (2007) Diastolic dysfunction in heart failure with preserved systolic function: Need for objective evidence:results from the CHARM Echocardiographic Substudy-CHARMES. J Am Coll Cardiol 49: 687-694.
29. Hawkins NM, Wang D, McMurray JJV, Pfeffer MA, Swedberg K, et al. (2007) Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: Evidence from the CHARM programme. Heart 93: 59-64.
30. De Blois J, Simard S, Atar D, Agewall S (2010) COPD predicts mortality in HF: The Norwegian Heart Failure Registry. J Card Fail 16: 225-229.
31. Harjola VP, Follath F, Nieminen MS, Brutsaert D, Dickstein K, et al. (2010) Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failure. Eur J Heart Fail 12: 239-248.
32. Goldberg RJ, Ciampa J, Lessard D, Meyer TE, Spencer FA (2007) Long-term survival after heart failure: A contemporary population-based perspective. Arch Intern Med 167: 490-496.
33. Pulignano G, Del Sindaco D, Tavazzi L, Lucci D, Gorini M, et al. (2002) Clinical features and outcomes of elderly outpatients with heart failure followed up in hospital cardiology units: Data from a large nationwide cardiology database (IN-CHF Registry). Am Heart J 143: 45-55.
34. Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, et al. (2008) Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: Findings from OPTIMIZE-HF. Arch Intern Med 168: 847-854.
35. Lee DS, Austin PC, Rouleau JL, Liu PP, Naimark D, et al. (2003) Predicting mortality among patients hospitalized for heart failure: Derivation and validation of a clinical model. JAMA 290: 2581-2587.
36. Anker SD, Ponikowski P, Varney S, Chua TP, Clark AL, et al. (1997) Wasting as independent risk factor for mortality in chronic heart failure. Lancet 349: 1050-1053.
37. Badheka AO, Rathod A, Kizilbash MA, Bhardwaj A, Ali O, et al. (2011) Comparison of mortality and morbidity in patients with atrial fibrillation and heart failure with preserved versus decreased left ventricular ejection fraction. Am J Cardiol 108: 1283-1288.
38. Brophy JM, Dagenais GR, McSherry F, Williford W, Yusuf S (2004) A multivariate model for predicting mortality in patients with heart failure and systolic dysfunction. Am J Med 116: 300-304.
39. Cygankiewicz I, Zareba W, Vazquez R, Bayes-Genis A, Pascual D, et al. (2009) Risk stratification of mortality in patients with heart failure and left ventricular ejection fraction.35%. Am J Cardiol 103: 1003-1010.
40. Horwich TB, Kalantar-Zadeh K, MacLellan RW, Fonarow GC (2008) Albumin levels predict survival in patients with systolic heart failure. Am Heart J 155: 883-889.
41. Liu M, Chan CP, Yan BP, Zhang Q, Lam YY, et al. (2012) Albumin levels predict survival in patients with heart failure and preserved ejection fraction. Eur J Heart Fail 14: 39-44.
42. Pocock SJ, Wang D, Pfeffer MA, Yusuf S, McMurray JJ, et al. (2006) Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J 27: 65-75.
43. Kwon BJ, Kim DB, Jang SW, Yoo KD, Moon KW, et al. (2010) Prognosis of heart failure patients with reduced and preserved ejection fraction and coexistent chronic obstructive pulmonary disease. Eur J Heart Fail 12: 1339-1344.
44. Linssen GC, Rienstra M, Jaarsma T, Voors AA, Van Gelder IC, et al. (2011) Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction. Eur J Heart Fail 13: 1111-1120.